Please contact our sales representative to learn more information about this reagents.
Background
Aducanumab, sold under the brand name Aduhelm, is a medication used to treat Alzheimer's disease (AD). It is an amyloid beta-directed monoclonal antibody. Aducanumab targets aggregated forms of Amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.